Eleven countries, eleven sets of paperwork

Organix has exported to eleven countries: Saudi Arabia, the UAE, Iraq, Jordan, Libya, Yemen, Turkey, China, Sierra Leone, Niger and Togo.

Look at the shape of that list rather than the length. Gulf markets, other Arab markets, a manufacturing power that exports supplements itself, one of the largest consumer markets on earth, and three West African countries. No single playbook covers those eleven. Each was its own project, and the manufacturing was the part that varied least.

That is the honest headline here. If you are planning to export supplements made in Egypt, your constraint will almost never be the factory.

What Egypt genuinely gives you

Four structural advantages, and they hold up to scrutiny:

Geography. Egypt sits between the Gulf, East and West Africa, Turkey and southern Europe. Freight times and costs from Sadat City to most of those destinations beat the alternatives a buyer is usually comparing against.

Manufacturing cost. Labour and conversion costs are materially lower than European equivalents, and the gap has widened rather than closed.

Trade agreements. Egypt holds arrangements that reduce or remove duty into a number of Arab and African markets. Where landed price decides the shelf, this is frequently the whole argument.

Capability that has caught up. Dr. Mohamed Anwar, who chairs Organix and heads the Egyptian Association of Food and Dietary Supplement Manufacturers and Exporters, treats this as the change that made the first three usable — Egyptian manufacturers reaching know-how comparable to the imported product, rather than merely undercutting it.

Nothing on that list is paperwork. That is the point.

The one thing Egypt does not give you: a single registration path

Requirements differ sharply by destination. Same product, same factory, same dossier — and two markets can be four months apart.

The variables that change market to market:

• Who holds the registration. You, your distributor, or a local importer of record. If it is the importer, your route to that market legally belongs to someone else — so the exclusivity conversation has to happen before the registration, not after.
• What the dossier contains. Specifications, stability data, ingredient justification and claim substantiation vary in depth by regulator.
• Whether a free-sale certificate from the country of manufacture is required. Some destinations insist on one, and that insistence pulls Egyptian product registration onto the critical path even for goods that will never be sold in Egypt.
• Label language, claims and mandatory statements. Different per market, and therefore different artwork per market.
• Ingredient lists. A permitted ingredient in one market is a restricted one in the next.
• Sequencing. Some regulators allow registration to run alongside manufacture. Others require clearance before a container moves.

That last variable is where the money is.

The asymmetry that costs Egyptian exporters orders

Here is the structural point, and it is not flattering.

In Egypt, a product manufactured for export still needs its own clearance. The factory being on the NFSA White List is not enough — the product is a separate file. In some competing manufacturing countries, a product made solely for export does not have to be registered domestically at all. Dr. Anwar puts it plainly:

"There they do not need to register products the way we do. What do you want? As long as the product is being made for export — make it and export it. Nobody asked whether you had registered it."

So two factories in two countries quote the same buyer. One ships. The other waits for a domestic clearance on goods that will never be sold domestically.

He has told that story with a specific case — a client exporting to Sierra Leone who spent five months in Egypt waiting, and received photographs during the wait of a container of the same product manufactured in Turkey and already shipped. That account is set out in what actually happens between your idea and your first pallet.

What is worth adding here is the diagnosis rather than the anecdote. That was not a capability gap. It was a rule asymmetry. The Egyptian factory could have produced it in the same window. The difference was a procedural requirement that the competing jurisdiction does not impose on export-only goods.

Three consequences for a buyer, and none is "avoid Egypt":

1. Start the Egyptian clearance on day one. Not after the sample, not after the trial batch. First.
2. Ask your manufacturer, in writing, what the current turnaround looks like for your product class — and treat a vague answer as the answer.
3. Price the wait into your comparison honestly. If a competing quote is months faster and you need the product for a season, that is a real difference, not a sales tactic.

It is also the kind of rule the sector is trying to change. The Egyptian Association of Food and Dietary Supplement Manufacturers and Exporters, which Dr. Anwar heads, was formed after a 2022 regulatory decision — 572, later followed by 725 — that could have stopped a substantial part of the sector operating. Its stated target is roughly USD 1 billion in Egyptian supplement exports by 2030.

West Africa, and why it is on the map

The most deliberate recent move has been toward West Africa — Senegal, Niger and Nigeria specifically.

The reasoning is geopolitical rather than promotional. French companies have been withdrawing from the region, and the products that dominated those shelves withdrew with them, leaving a gap in a category with genuine demand. Dr. Anwar is explicit that this followed a great deal of study rather than an impulse: the question asked was where the real gap in supplements on the African continent sits, and the answer came back West Africa.

Two honest qualifications:

The gap is not an empty room. Turkish companies are competing hard for the same opening, with the procedural advantage described above. Anyone presenting West Africa as uncontested is selling something.

Registration is country by country, and lighter is not the same as light. Niger, Togo and Sierra Leone are already in the Organix export record, so the paperwork is navigable. It is not uniform. In each market the first question to settle is who holds the registration locally, because that determines who controls your access.

What actually consumes the time

In rough order of how much of your calendar each one takes:

1. Destination registration — months, and sequenced according to that regulator's rules, not yours.
2. Egyptian product clearance — months, required even for export-only goods.
3. Label compliance and translated artwork — weeks per market, and it cannot be finalised until the registration details are.
4. Appointing an importer or agent — weeks, and the commercial terms take longer than the appointment.
5. Document legalisation and attestation — days to weeks, and routinely forgotten until a shipment is waiting.
6. Manufacturing — the shortest of these.
7. First-shipment inspection at destination — budget for it, and for the possibility that it goes badly.

If an export plan has manufacturing as its longest bar, the plan is wrong.

Before you commit to an Egyptian supplier for export

• Which countries, in which order, and which one pays for the launch?
• Who will hold the registration in each market — you, a distributor, or an importer?
• Does your destination require a free-sale certificate from Egypt? If so, your Egyptian clearance is on the critical path whatever else happens.
• Has this factory shipped to your destination before? Ask which countries, and when. "We export" is not an answer; a list with dates is.
• Does your dosage form survive the freight economics? Liquids mean paying to ship water — see thirteen dosage forms, and how to pick the right one.
• Have you budgeted artwork per market rather than once?
• Who carries the cost if a shipment is rejected at the destination port?
• What certifications does the destination buyer actually ask for? FSSC 22000 and a pharmaceutical-grade GMP classification carry weight in some import files and none at all in others.

For the record: Organix has been in production since 2020, holds seven certifications including FSSC 22000 and GMP at Class D Pharmaceutical classification, and has exported to the eleven countries named at the top of this article. Uzbekistan is currently being explored as a twelfth.

Egypt's advantages here are structural. Its paperwork is the part you have to project-manage. Separate the two and the sourcing decision gets much easier.